RECRUITING

bpMedManage: Digital Technology to Support Adherence to Hypertension Medications

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the bpMedManage study is to rigorously test the efficacy of a smartphone technology to help improve high blood pressure medication adherence among older adults with mild cognitive impairment (MCI) in a 16-week randomized controlled trial. A total of 100 older adults will be recruited. There will be two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on an education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes on primary and secondary measures will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.

Official Title

Digital Technology to Support Adherence to Hypertension Medications for Older Adults With Mild Cognitive Impairment

Quick Facts

Study Start:2024-02-29
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06307574

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 60+
  2. 2. Community-dwelling older adults
  3. 3. Self-reported fluent in English
  4. 4. Adequate self-reported visual and hearing ability
  5. 5. Self-reported memory, thinking, or concentration challenges
  6. 6. Self-manage at least one prescribed antihypertensive medication
  7. 7. Have and use a smartphone
  8. 8. No self-reported history of major depression or other mental health diagnoses
  9. 9. No self-reported diagnosis of dementia or other neurological disorder such as stroke, TBI, and Parkinson's disease
  10. 10. TICS-M score between 27-37 and Montreal Cognitive Assessment (MoCA) score between 20-26
  11. 11. Willing to participate in the study for at least 4 months
  1. 1. Diagnosis of dementia
  2. 2. Lives in assisted living facility or skilled nursing facility

Contacts and Locations

Study Contact

Kathleen Insel, PhD
CONTACT
520-626-6220
insel@arizona.edu
Raksha Mudar, PhD
CONTACT
217-333-4718
raksha@illinois.edu

Principal Investigator

Kathleen Insel, PhD
PRINCIPAL_INVESTIGATOR
University of Arizona
Raksha Mudar, PhD
PRINCIPAL_INVESTIGATOR
University of Illinois, Urbana-Champaign

Study Locations (Sites)

University of Arizona
Tucson, Arizona, 85721
United States
University of Illinois, Urbana-Champaign
Champaign, Illinois, 61820
United States

Collaborators and Investigators

Sponsor: University of Arizona

  • Kathleen Insel, PhD, PRINCIPAL_INVESTIGATOR, University of Arizona
  • Raksha Mudar, PhD, PRINCIPAL_INVESTIGATOR, University of Illinois, Urbana-Champaign

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-29
Study Completion Date2025-12

Study Record Updates

Study Start Date2024-02-29
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • Digital Health Intervention
  • Medication Adherence
  • Mobile Application
  • Mild Cognitive Impairment
  • Aging
  • Hypertension

Additional Relevant MeSH Terms

  • Aging
  • Mild Cognitive Impairment
  • Hypertension